NEOGENOMICS INC — Director's Dealing 2012

Jun 8, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-06-07

Reporting Person: DENT MICHAEL T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-07	Common Stock	A	10500	$1.5	Acquired	34500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1603050	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$0.25	2014-08-14	Common Stock (0)	400000	Direct

Footnotes

F1: Mr. Dent did a cashless net exercise of 100,000 warrants which resulted in him receiving 10,500 shares of common stock. On April 27,2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Dent remains a Director of the Company.